Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center
- PMID: 19474267
- PMCID: PMC2708468
- DOI: 10.1128/JCM.01834-08
Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center
Abstract
All patients admitted to our tertiary care hospital from 1 December 2007 to 10 June 2008 were screened for methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) nasal colonization, and the isolates were tested for mupirocin susceptibility by using Etest. Mupirocin resistance (MR) was noted to occur in 3.4% of MRSA carriers, and high-level MR was noted to occur in 0.62% of carriers.
References
-
- Annigeri, R., J. Conly, S. Vas, et al. 2001. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit. Dial. Int. 21554-559. - PubMed
-
- Casewell, M. W., and R. L. R. Hill. 1987. Mupirocin (“pesudomonic acid”)—a promising new topical antimicrobial agent. J. Antimicrob. Chemother 191-5. - PubMed
-
- Cookson, B. D. 1998. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 4111-18. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical